Charles River Laboratories
339 hedge funds and large institutions have $5.16B invested in Charles River Laboratories in 2017 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 129 increasing their positions, 113 reducing their positions, and 46 closing their positions.
189% more call options, than puts
Call options by funds: $6.01M | Put options by funds: $2.08M
14% more repeat investments, than reductions
Existing positions increased: 129 | Existing positions reduced: 113
11% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 46
3.24% more ownership
Funds ownership: 96.5% → 99.74% (+3.2%)
4% more capital invested
Capital invested by funds: $4.96B → $5.16B (+$201M)
1% more funds holding
Funds holding: 336 → 339 (+3)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
+$148M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
+$64.2M |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
+$29M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$27.6M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$20.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$87.6M |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
-$35.6M |
| 3 |
D.E. Shaw & Co
New York
|
-$24.1M |
| 4 |
Millennium Management
New York
|
-$23.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$20.8M |
CRL Hedge Fund Activity: Q4 2017 in Review
339 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2017, worth a combined $5.16B — up 4.1% from $4.96B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new CRL positions and 46 closed out — a net gain of 5 holders — while 129 added to existing stakes and 113 trimmed.
The largest buyer was William Blair Investment Management, adding an estimated $148M. The largest seller was Morgan Stanley, cutting an estimated $87.6M.
- 339 institutional investors held Charles River Laboratories (CRL) as of Q4 2017, up from 336 in Q3 2017.
- Funds reported $5.16B of Charles River Laboratories stock for Q4 2017, up 4.1% quarter-over-quarter.
- 51 funds opened new Charles River Laboratories positions in Q4 2017 and 46 closed out, a net change of +5 holders.
- The largest Charles River Laboratories buyer in Q4 2017 was William Blair Investment Management, an estimated $148M added.
- The largest Charles River Laboratories seller in Q4 2017 was Morgan Stanley, an estimated $87.6M sold.
Based on aggregated 13F filings for Q4 2017.